Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - CAPRICOR THERAPEUTICS, INC.v433695_ex32-1.htm
EX-31.2 - EXHIBIT 31.2 - CAPRICOR THERAPEUTICS, INC.v433695_ex31-2.htm
EX-21.1 - EXHIBIT 21.1 - CAPRICOR THERAPEUTICS, INC.v433695_ex21-1.htm
EX-32.2 - EXHIBIT 32.2 - CAPRICOR THERAPEUTICS, INC.v433695_ex32-2.htm
EX-31.1 - EXHIBIT 31.1 - CAPRICOR THERAPEUTICS, INC.v433695_ex31-1.htm
EX-10.59 - EXHIBIT 10.59 - CAPRICOR THERAPEUTICS, INC.v433695_ex10-59.htm
10-K - FORM 10-K - CAPRICOR THERAPEUTICS, INC.v433695_10k.htm

 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Stockholders of Capricor Therapeutics, Inc.

Los Angeles, California

 

We consent to the incorporation by reference in the Registration Statements of Capricor Therapeutics, Inc. on Form S-8 (File Nos. 333-152283, 333-175727, and 333-194317) and Form S-3 (File Nos. 333- 207149, 333-195385, and 333-202589) of our report dated March 28, 2016, relating to the consolidated financial statements, appearing in this Annual Report on Form 10-K. 

 

/s/ Rose, Snyder & Jacobs LLP  
   
Rose, Snyder & Jacobs LLP  
Encino, California  
   
March 28, 2016